Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Annales D'Endocrinologie
|
December 20, 2016
PET imaging for thyroid cancers: Current status and future directions
Anne-Laure Giraudet, David Taïeb
Clinical Nuclear Medicine
|
May 24, 2021
Incidental Finding of Hibernoma in Prostate-Specific Membrane Antigen PET/CT
Aurélie Moreau, Thierry Cruel, Anne Laure Giraudet, et al.
Clinical Nuclear Medicine
|
April 17, 2024
Radionuclide Therapy With 177 Lu-PSMA in a Patient With Hepatocellular Carcinoma
Valentin Pretet, Anne Laure Giraudet, Laure Vergnaud, et al.
Clinical Nuclear Medicine
|
September 12, 2022
Intense Diffuse Lung Uptake Due to Interstitial Pneumopathy Related to Polyangiitis Granulomata in 68 Ga-PSMA-11 PET/CT
Aurélie Moreau, Valentin Pretet, Emilie Paquet, et al.
Clinical Nuclear Medicine
|
January 6, 2023
Unintentional Intra-arterial Injection of 177Lu-PSMA-1 in a Patient With a Peritoneal Carcinosis Secondary to a Metastatic Prostate Cancer
David Kryza, Aurélie Moreau, Jean Noël Badel, et al.
EJNMMI Physics
|
July 18, 2024
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?
Laure Vergnaud, Yuni K Dewaraja, Anne-Laure Giraudet, et al.
EJNMMI Radiopharmacy and Chemistry
|
June 23, 2026
Fully GMP-complient radiosynthesis of [<sup>161</sup>Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation
David Kryza, Pierre Le Fur, Jean Noël Badel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Phase III Study of <sup>18</sup>F-PSMA-1007 Versus <sup>18</sup>F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, et al.
European Urology Focus
|
May 26, 2026
Radioligand Therapy (RLT) in France
Anne-Laure Giraudet, David Kryza, Lavinia Vija, et al.
EJNMMI Physics
|
May 16, 2022
Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for <math> </math>Lu-DOTATATE therapy
Laure Vergnaud, Anne-Laure Giraudet, Aurélie Moreau, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Annales D'Endocrinologie
|
December 20, 2016
PET imaging for thyroid cancers: Current status and future directions
Anne-Laure Giraudet, David Taïeb
Clinical Nuclear Medicine
|
May 24, 2021
Incidental Finding of Hibernoma in Prostate-Specific Membrane Antigen PET/CT
Aurélie Moreau, Thierry Cruel, Anne Laure Giraudet, et al.
Clinical Nuclear Medicine
|
April 17, 2024
Radionuclide Therapy With 177 Lu-PSMA in a Patient With Hepatocellular Carcinoma
Valentin Pretet, Anne Laure Giraudet, Laure Vergnaud, et al.
Clinical Nuclear Medicine
|
September 12, 2022
Intense Diffuse Lung Uptake Due to Interstitial Pneumopathy Related to Polyangiitis Granulomata in 68 Ga-PSMA-11 PET/CT
Aurélie Moreau, Valentin Pretet, Emilie Paquet, et al.
Clinical Nuclear Medicine
|
January 6, 2023
Unintentional Intra-arterial Injection of 177Lu-PSMA-1 in a Patient With a Peritoneal Carcinosis Secondary to a Metastatic Prostate Cancer
David Kryza, Aurélie Moreau, Jean Noël Badel, et al.
EJNMMI Physics
|
July 18, 2024
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?
Laure Vergnaud, Yuni K Dewaraja, Anne-Laure Giraudet, et al.
EJNMMI Radiopharmacy and Chemistry
|
June 23, 2026
Fully GMP-complient radiosynthesis of [<sup>161</sup>Tb]Tb-PSMA-1 using the miniAiO synthesizer for clinical translation
David Kryza, Pierre Le Fur, Jean Noël Badel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Phase III Study of <sup>18</sup>F-PSMA-1007 Versus <sup>18</sup>F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
Pierre Olivier, Anne-Laure Giraudet, Andrea Skanjeti, et al.
European Urology Focus
|
May 26, 2026
Radioligand Therapy (RLT) in France
Anne-Laure Giraudet, David Kryza, Lavinia Vija, et al.
EJNMMI Physics
|
May 16, 2022
Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for <math> </math>Lu-DOTATATE therapy
Laure Vergnaud, Anne-Laure Giraudet, Aurélie Moreau, et al.
Page
of 4